Building a better understanding of the burden of disease in familial chylomicronemia syndrome
Open Access
- 8 November 2016
- journal article
- editorial
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 10 (1) , 1-3
Abstract
(2017). Building a better understanding of the burden of disease in familial chylomicronemia syndrome. Expert Review of Clinical Pharmacology: Vol. 10, No. 1, pp. 1-3.Keywords
Funding Information
- Akcea Therapeutics
This publication has 9 references indexed in Scilit:
- Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care systemJournal of Clinical Lipidology, 2016
- Targeting APOC3 in the Familial Chylomicronemia SyndromeNew England Journal of Medicine, 2014
- Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1Journal of Clinical Lipidology, 2014
- Genotype-phenotype relationships in patients with type I hyperlipoproteinemiaJournal of Clinical Lipidology, 2014
- Chronic Pancreatitis and Its Effect on Employment and Health Care ExperiencePancreas, 2010
- Practice Guidelines in Acute PancreatitisAmerican Journal of Gastroenterology, 2006
- Pancreatitis in ChildrenJournal of Pediatric Gastroenterology and Nutrition, 2003
- Acute Pancreatitis in ChildrenAmerican Journal of Gastroenterology, 2002
- Late mortality in patients with severe acute pancreatitisBritish Journal of Surgery, 2001